Company Filing History:

5 out of 389

Sanofi-aventis

Years Active: 2005-2007

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7223750 - Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics (2007-05-29),

2. 7220740 - 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof (2007-05-22),

3. 7119087 - 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof (2006-10-10),

4. 7022697 - 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof (2006-04-04),

5. 7001902 - 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof (2006-02-21),

6. 6998399 - 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof (2006-02-14),

7. 6908927 - Pyridopyranoazepine derivatives, their preparation and their therapeutic application (2005-06-21),

8. 6844337 - 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, their preparation and their application in therapeutics (2005-01-18),

Title: Frédéric Galli: Innovator in Therapeutic Compounds

Introduction

Frédéric Galli is a notable inventor based in Vaucresson, France. He has made significant contributions to the field of therapeutics, holding a total of eight patents. His work focuses on the development of innovative compounds that have potential applications in medicine.

Latest Patents

Galli's latest patents include "Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics." This patent describes compounds that comply with a specific general formula, where R can represent various substituents, including halogen atoms and phenyl groups. Another significant patent is for "1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof." This patent outlines compounds with therapeutic applications, where X can be an oxygen or sulfur atom, or an NH group.

Career Highlights

Throughout his career, Frédéric Galli has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis and Sanofi-Synthelabo. His experience in these organizations has allowed him to develop and refine his innovative ideas in therapeutic compounds.

Collaborations

Galli has collaborated with notable colleagues such as Alistair Lochead and Odile LeClerc. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Frédéric Galli's work in the field of therapeutics showcases his dedication to innovation and invention. His patents reflect a commitment to advancing medical science through the development of new compounds.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.